3 Questions on... The Number of Patients With Cancer Who Stay on Opioids After Surgery: With Jay S. Lee, MD, Surgical Oncology Research Fellow at University of Michigandoi:10.1097/01.COT.0000528049.39092.7cSarah DiGiulioOncology Times
All data were obtained from the surveillance, epidemiology, and end results (SEER) database, which provides information on cancer statistics to reduce the cancer burden among the US population18. The profiles of patients who underwent surgical treatment for MEC of the major salivary gland between ...
EUSA Pharma, at number 39, already has cancer drugs on the market and has FDA regulatory clearance for a stage 3 clinical trial testing its siltuximab drug in COVID-19 after showing an increase in patient survival rates. Since its launch, 1,200 companies have featured on Tech Track 100 and...
The four-herb Chinese medicine PHY906(KD018) has been shown to both enhance the in vivo antitumor activity of irinotecan (CPT-11) against colon cancer tumor allografts and alleviate intestinal toxicity caused by CPT-11. Since intestinal bacteria can meta
“In the past dozens of years, the number of smoker lung cancer patients didn’t reduce, while we saw more non-smokers also suffered this disease, which can be related with kitchen smoke, air pollution and life style,” Chen said. “More researches are required to study those...
NUMBER NEEDED TO TREAT (NNT) AS A MEASURE OF ZOLEDRONIC ACID (ZOL) EFFICACY IN PATIENTS WITH HORMONE-RESPONSIVE EARLY BREAST CANCER (BC) IN THE AUSTRIAN BR... M Gnant,B Mlineritsch,W Schippinger,... - Impakt Breast Cancer Conference 被引量: 0发表: 2009年 Interpreting results from ...
Copy-number variation (CNV), rather than complete loss of gene function, is increasingly implicated in human disease. Moreover, gene dosage is recognised as important in tumourigenesis, and there is an increasing realisation that CNVs may not be just symptomatic of the cancerous state but may, ...
Advanced-cancer patients decline in immune functions and quality of life (QOL). The study's subjects were patients with inoperable colorectal, liver, or pancreatic cancer. In a randomized double-blind trial, AGE was administered to one group and a placebo was administered to another for 6 mo....
The contribution of germline copy number variants (CNVs) to risk of developing cancer in individuals with pathogenic BRCA1 or BRCA2 variants remains relatively unknown. We conducted the largest genome-wide analysis of CNVs in 15,342 BRCA1 and 10,740 BRCA
copy number between serous tubal intraepithelial carcinoma and high-grade serous carcinoma in the same patients (P<0.001). There was no significant difference in the percentage of CCNE1 gain/amplification between serous tubal intraepithelial carcinoma and high-grade serous carcinoma (P...